HAEMATOLOGY

Abbrev. Title

ALLG AML M22

Protocol Title

A randomized, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in subjects with acute myeloid Leukaemia in first complete remission

Aplastic Anaemia Registry Monash University - Aplastic Anaemia Registry

D8227C00001 ESCALADE ACE-LY-312

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤ 70 Years with Previously Untreated Non-GCB DLBCL

GS-US-352-4365 SRAMMB-352-4365

Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Postpolycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

KRT-232-101 BOREAS

A Phase 2/3 Randomized, Controlled, Open-Label Study of KRT 232 in Subjects with Primary Myelofibrosis (PMF), Post Polycythemia Vera MF (Post-PV-MF), Or Post Essential Thrombocythemia MF (Post-ET-MF) Who Are Relapsed or Refractory to Janus Kinase (JAK) Inhibitor Treatment

LOXO-BTK-20019 BRUINMCL-321

A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma

M07-001 PNH Registry Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

MDS Database

A retrospective/prospective study of patients with Myelodysplasia in South Australia–diagnostic phenotype, outcome and the risk of iron overload

MRDR Database Myeloma and Related Disease Registry